This website uses cookies

Read our Privacy policy and Terms of use for more information.

In partnership with

The Bottom Line Upfront 💡

QUBT $QUBT ( ▼ 5.78% ) is a pre-revenue quantum computing lab wrapped around a $1.5B cash pile. The differentiated room-temperature photonics tech is real, but so is relentless dilution. You’re buying a cash box with a lottery ticket attached — invest in the science, not the vibes.

Sponsorship

You Can’t Lead If You’re Stuck in the Middle

Most business owners don’t notice when it happens.

They start as the operator… and slowly become the center of everything.

The real risk isn’t being busy. It’s being required for everything.

BELAY’s new guide From Operator to Owner: How to Exit the Middle Without Losing Control shows you how to step out of day-to-day execution while keeping visibility, quality, and momentum intact.

BELAY matches you with U.S.-based Assistants who bring structure, follow-through, and operational clarity so work keeps moving without you at the center.

Strata Layers Chart

Layer 1: The Business Model 🏛️

QUBT builds quantum computers — but with a twist. While competitors like IBM and Google use superconducting qubits requiring cooling to near absolute zero (colder than outer space), QUBT uses photonics — particles of light — to compute at room temperature. No liquid helium. No exotic cooling rigs. Just a regular server rack.

Their flagship product is the Entropy Quantum Computer (EQC), branded as the “Dirac” series (currently on Dirac-3, with Dirac-4 in development). It solves complex optimization problems — think “What’s the most efficient delivery route for 10,000 packages?” or “How do I build the best drug molecule?” Customers access it via cloud or on-premises.

Beyond quantum computing, QUBT’s portfolio includes:

  • 🤖 Neurawave — a photonics-based AI edge device

  • 📡 Quantum Photonic Vibrometer — remote vibration sensing (detecting structural defects from a distance)

  • 🔒 Quantum Authentication — ultra-secure network communication

  • 🏭 TFLN Optical Chips — custom photonic chips sold via their Arizona foundry

Revenue comes from services (R&D contracts, proof-of-concept work) and products (hardware sales). In 2025, product revenue exploded from $27K to $314K ↗️ — still tiny, but the direction is right.

Key Takeaway: QUBT is betting room-temperature photonic quantum computing will win the quantum race — selling picks and shovels (chips, sensors, AI hardware) while waiting for the gold rush.

Layer 2: Category Position 🏆

The quantum computing landscape is crowded and brutal. QUBT competes against:

  • Tech giants: IBM, Google, Microsoft, Amazon, Intel — each with billions in R&D

  • Pure-play startups: IonQ, Rigetti, D-Wave, Xanadu, PsiQuantum

  • Government programs: China, EU, UK — not scrappy underdogs

There are 400+ companies focused on quantum computing. QUBT’s differentiation is real but unproven at scale: room-temperature operation is genuinely cheaper and simpler than cryogenic systems. The question is whether photonics can match the computational power of superconducting rivals.

QUBT’s moat today is thin — 3 core patents (plus 23 from the Luminar acquisition), a small but growing IP portfolio, and a head start in photonic chip manufacturing via Arizona. They’re not winning on brand or customer relationships yet.

Key Takeaway: QUBT has a genuinely differentiated technical approach, but it’s a 72-person company competing against trillion-dollar giants — David vs. several Goliaths, simultaneously.

Layer 3: Show Me The Money! 📈

Let’s be honest: the financials are rough. Here’s the full picture.

Revenue Breakdown (2025)

  • Services: $368K (54%) ↘️ share

  • Products: $314K (46%) ↗️ share — this shift matters

  • Americas: $592K | Europe: $65K | Asia: $25K

The Cost Problem

  • Gross margin: 10% ↘️ (was 30% in 2024, 45% in 2023) — wrong direction

  • Operating expenses: $51.1M ↗️ against $682K in revenue

  • R&D: $20.5M | G&A: $27.2M | Sales & Marketing: $3.4M

The Silver Lining

  • Net loss improved to $18.7M in 2025 vs. $68.5M in 2024 ↗️ — mostly from $20.7M in interest income on their cash pile and an $11.8M non-cash warrant gain

  • Operating cash burn: $30.3M/year

  • Cash + investments: $1.52 billion — raised $1.475B in 2025 through four private placements

The company is essentially a cash box with a quantum computing lab attached. At $30M annual burn, they have ~50 years of runway. But burn will accelerate, and dilution is relentless — shares grew from 77M (end of 2023) to 224M today ↗️📉.

Key Takeaway: QUBT’s story is “we raised a ton of money and spend it on R&D.” The business generates almost no revenue, but the cash buys time to prove the technology.

Layer 4: Long-Term Valuation (DCF Model) 💰

Here it gets philosophically interesting. QUBT can’t be valued on traditional DCF fundamentals — the operating business has negative value in every scenario. The stock is essentially: cash per share + a lottery ticket on quantum computing.

The Verdict: Speculative / Cash-Supported Option Play

Scenario

Fair Value

vs. Current Price (~$8.33)

Bear Case (dilution + failure)

$0.68

-93%

Conservative

$10.53

+3%

Base Case

$11.18

+9%

Optimistic

$13.52

+32%

Key Assumptions:

  • Cash/investments of $1.52B ($11.13/share) is the primary value anchor

  • Revenue reaching ~$27M by 2030 (from $682K today) — aggressive but not insane

  • Dilution is the killer: if shares reach 400M+, per-share value collapses to ~$3-5

The bear case isn’t “quantum computing fails” — it’s “they keep issuing shares until your slice of the pie is crumbs.”

One-line take: You’re mostly buying a cash box with a quantum computing option attached — just make sure the option doesn’t get diluted into oblivion.

Layer 5: What Do We Have to Believe? 📚

Bull Case 🚀

  • Photonics wins the race: Room-temperature operation becomes the standard, and QUBT’s head start in TFLN chip manufacturing creates a durable moat

  • Luminar pays off: The $110M purchase of Luminar Semiconductor’s photonics capabilities accelerates chip revenue and opens aerospace/defense contracts

  • Revenue inflects: The services-to-products shift continues, and TFLN foundry services generate scalable revenue by 2027-2028

Bear Case 🐻

  • Dilution destroys per-share value: Shares tripled in two years; another raise could push past 400M, halving cash-per-share

  • Quantum winter arrives: Commercialization slips, customers stay cautious, and $682K revenue never scales

  • Legal overhang: An active SEC securities class action + four shareholder derivative suits = distraction, costs, and potential liability

The Bottom Line: QUBT is a high-conviction bet on a specific quantum technology that hasn’t proven commercial viability. The cash provides a floor — but that floor erodes with every share issuance. This is a stock for investors who genuinely believe photonic quantum computing will matter AND that QUBT survives. Everyone else should watch from the sidelines.

Layer 6: What to Watch 👀

  1. Revenue trajectory 🎯 — Watch for quarterly revenue crossing $1M, then $5M. Any meaningful contract is a catalyst. The 2026 executive comp plan targets $30M revenue — that’s the goalpost.

  2. Share count creep 📉 — Currently 224M shares. If this nears 350M+ without proportional revenue growth, the per-share math gets ugly. Monitor every 8-K for new offerings.

  3. Luminar integration 🔧 — The $110M acquisition closed February 2026. Watch whether LSI’s aerospace/defense revenue shows up in 2026 results — the biggest near-term catalyst.

  4. Securities class action outcome ⚖️ — The lawsuit alleging misleading statements about customers and contracts is still active. A bad outcome could be materially damaging.

  5. Gross margin recovery 📊 — Margins collapsed 45% → 30% → 10% over three years. If the trend doesn’t reverse as TFLN chips scale, the business model has a fundamental problem. Watch for margins to stabilize above 30%.

AI-written, human-approved

Disclaimer: This guide is for informational purposes only and does not constitute financial advice, investment recommendations, or an offer or solicitation to buy or sell any securities. The information contained in this report has been obtained from sources believed to be reliable, but StrataFinance does not guarantee its accuracy, completeness, or timeliness.

More From Capital

View more
caret-right